Answers are grounded in this paper and cite their sources.
The GEP score is a clinically significant prognostic tool, contributes additional information regarding the MSS of melanoma patients, and complements conventional staging.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: